Skip to main content

Towards evidence‐based use of serum tumour marker requests: an audit of use in a tertiary hospital

Buy Article:

$51.00 plus tax (Refund Policy)

Abstract:

Background : Serum tumour markers (TM) are often measured in hospital patients. The reasons for their use and their benefits with regards to earlier cancer diag­nosis and patient management are not known.

Keywords: AFP; CA 15‐3; CA 19‐9; CA‐124; CEA; guidelines; tumour markers

Document Type: Research Article

DOI: https://doi.org/10.1111/j.1445-5994.2004.00671.x

Affiliations: 1: Department of Medical Oncology and Haematology, Peter MacCallum Cancer Centre, and Departments of 2: Medical Oncology and 3: Biochemistry, Alfred Hospital, Melbourne, Victoria, Australia

Publication date: 2004-09-01

  • Access Key
  • Free ContentFree content
  • Partial Free ContentPartial Free content
  • New ContentNew content
  • Open Access ContentOpen access content
  • Partial Open Access ContentPartial Open access content
  • Subscribed ContentSubscribed content
  • Partial Subscribed ContentPartial Subscribed content
  • Free Trial ContentFree trial content
Cookie Policy
X
Cookie Policy
Ingenta Connect website makes use of cookies so as to keep track of data that you have filled in. I am Happy with this Find out more